Researchers recommend ‘caution’ when using the chemotherapy busulfan in patients with Gilbert’s syndrome
Oct. 27, 2016
| By Susan Keown / Fred Hutch News Service
As many as one of every 10 people has Gilbert's syndrome, which is typically benign and has even been linked to long life. But new research suggests that busulfan, a bone marrow transplant drug, is extra risky in people with the condition.